These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 11205212

  • 1. Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors.
    Lumachi F, Brandes AA, Ermani M, Bruno G, Boccagni P.
    Anticancer Res; 2000; 20(6C):4751-5. PubMed ID: 11205212
    [Abstract] [Full Text] [Related]

  • 2. Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer.
    Lumachi F, Basso SM, Brandes AA, Pagano D, Ermani M.
    Anticancer Res; 2004; 24(5B):3221-4. PubMed ID: 15510614
    [Abstract] [Full Text] [Related]

  • 3. Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer.
    Lumachi F, Basso SM, Bonamini M, Marzano B, Milan E, Waclaw BU, Chiara GB.
    Anticancer Res; 2010 Jun; 30(6):2331-4. PubMed ID: 20651388
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3.
    Lumachi F, Brandes AA, Boccagni P, Polistina F, Favia G, D'Amico DF.
    Anticancer Res; 1999 Jun; 19(5C):4485-9. PubMed ID: 10650797
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
    Samy N, Ragab HM, El Maksoud NA, Shaalan M.
    Cancer Biomark; 2010 Jun; 6(2):63-72. PubMed ID: 20571232
    [Abstract] [Full Text] [Related]

  • 6. Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
    Ebeling FC, Schmitt UM, Untch M, Nagel D, Fateh-Moghadam A, Stieber P, Seidel D.
    Anticancer Res; 1999 Jun; 19(4A):2545-50. PubMed ID: 10470192
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of different prognostic factors in breast cancer recurrences: multivariate analysis using a logistic regression model.
    Lumachi F, Ermani M, Brandes AA, Basso S, Basso U, Boccagni P.
    Anticancer Res; 2001 Jun; 21(6A):4105-8. PubMed ID: 11911301
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients.
    Laessig D, Nagel D, Heinemann V, Untch M, Kahlert S, Bauerfeind I, Stieber P.
    Anticancer Res; 2007 Jun; 27(4A):1963-8. PubMed ID: 17649806
    [Abstract] [Full Text] [Related]

  • 10. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
    Guadagni F, Ferroni P, Carlini S, Mariotti S, Spila A, Aloe S, D'Alessandro R, Carone MD, Cicchetti A, Ricciotti A, Venturo I, Perri P, Di Filippo F, Cognetti F, Botti C, Roselli M.
    Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
    [Abstract] [Full Text] [Related]

  • 11. Hormone receptor rate, MIB-1 score and serum tumour markers CEA and CA 15-3 relationship in elderly women with pT1-2 breast cancer.
    Lumachi F, Norberto L, Marino F, Basso SM, Marzano B, Chiara GB.
    Anticancer Res; 2010 Nov; 30(11):4701-4. PubMed ID: 21115927
    [Abstract] [Full Text] [Related]

  • 12. Prospective evaluation of CEA and CA 15.3 in patients with locoregional breast cancer.
    Molina R, Filella X, Alicarte J, Zanon G, Pahisa J, Munoz M, Farrus B, Ballesta AM.
    Anticancer Res; 2003 Nov; 23(2A):1035-41. PubMed ID: 12820344
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 14. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
    Eskelinen M, Kataja V, Hämäläinen E, Kosma VM, Penttilä I, Alhava E.
    Anticancer Res; 1997 Apr 12; 17(2B):1231-4. PubMed ID: 9137478
    [Abstract] [Full Text] [Related]

  • 15. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J.
    Magy Onkol; 2007 Apr 12; 51(2):127-31. PubMed ID: 17660868
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of CEA and CA 15-3 in the follow up of invasive breast cancer.
    Sütterlin M, Bussen S, Trott S, Caffier H.
    Anticancer Res; 1999 Apr 12; 19(4A):2567-70. PubMed ID: 10470196
    [Abstract] [Full Text] [Related]

  • 17. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
    Kurebayashi J, Nomura T, Hirono M, Okubo S, Udagawa K, Shiiki S, Ikeda M, Nakashima K, Tanaka K, Sonoo H.
    Jpn J Clin Oncol; 2006 Mar 12; 36(3):150-3. PubMed ID: 16520359
    [Abstract] [Full Text] [Related]

  • 18. Clinical value of TPS, CEA and CA 15-3 in breast cancer patients.
    Blijlevens NM, Oosterhuis WP, Oosten HR, Mulder NH.
    Anticancer Res; 1995 Mar 12; 15(6B):2711-6. PubMed ID: 8669851
    [Abstract] [Full Text] [Related]

  • 19. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT, Olivotto IA, Speers CH, Wai ES, Berthelet E, Kader HA.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):797-804. PubMed ID: 14967436
    [Abstract] [Full Text] [Related]

  • 20. Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery.
    Nakamura T, Kimura T, Umehara Y, Suzuki K, Okamoto K, Okumura T, Morizumi S, Kawabata T.
    Surg Today; 2005 Mar 01; 35(1):19-21. PubMed ID: 15622458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.